Paolo Cavanni

728 total citations
21 papers, 405 citations indexed

About

Paolo Cavanni is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Paolo Cavanni has authored 21 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in Paolo Cavanni's work include Neuroscience and Neuropharmacology Research (12 papers), Receptor Mechanisms and Signaling (8 papers) and Chemical Synthesis and Analysis (3 papers). Paolo Cavanni is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Receptor Mechanisms and Signaling (8 papers) and Chemical Synthesis and Analysis (3 papers). Paolo Cavanni collaborates with scholars based in Italy, United Kingdom and Austria. Paolo Cavanni's co-authors include Fabrizio Micheli, Christian Heidbreder, Romano Di Fabio, Daniele Donati, Massimiliano Bianchi, Rosaria Remelli, Francesco Crespi, Raffaella Vergura, Severo Salvadori and Laurent Lacroix and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

Paolo Cavanni

21 papers receiving 393 citations

Peers

Countries citing papers authored by Paolo Cavanni

Since Specialization

Citations

This map shows the geographic impact of Paolo Cavanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Cavanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Cavanni more than expected).

Fields of papers citing papers by Paolo Cavanni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Cavanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Cavanni. The network helps show where Paolo Cavanni may publish in the future.

Co-authorship network of co-authors of Paolo Cavanni

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Cavanni. A scholar is included among the top collaborators of Paolo Cavanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Cavanni. Paolo Cavanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1,2,4-Triazolyl octahydropyrrolo[2,3-b]pyrroles: A new series of potent and selective dopamine D3 receptor antagonists 2016 ·Bioorganic & Medicinal Chemistry ·Fabrizio Micheli, (unknown), Federica Bianchi, Simone Braggio, Laura Castelletti, (unknown), Paolo Cavanni, (unknown), (unknown), Aldo Feriani, Beatrice Oliosi, (unknown), Luca Tarsi, Silvia Tomelleri, (unknown), (unknown), Laura Zonzini, Christian Heidbreder	17
2	Novel morpholine scaffolds as selective dopamine (DA) D3 receptor antagonists 2016 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli, (unknown), (unknown), Luca Tarsi, Silvia Tomelleri, Paolo Cavanni, Beatrice Oliosi, (unknown), Anna Sava, Laura Zonzini, Aldo Feriani, Simone Braggio, Christian Heidbreder	19
3	1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors 2011 ·Bioorganic & Medicinal Chemistry ·Fabrizio Micheli, Paolo Cavanni, Michela Bettati, Giorgio Bonanomi, Romano Di Fabio, (unknown), Carla Marchioro, (unknown), Luca Tarsi, (unknown), Laura Zonzini, Angela Worby	4
4	Slow dissociation of partial agonists from the D2 receptor is linked to reduced prolactin release 2011 ·The International Journal of Neuropsychopharmacology ·Lucia Carboni, (unknown), Francesca Michielin, Simone Bertani, (unknown), Beatrice Oliosi, Paolo Cavanni	19
5	Phenylethynyl-pyrrolo[1,2-a]pyrazine: A new potent and selective tool in the mGluR5 antagonists arena 2008 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli, Barbara Bertani, (unknown), Luca Crippa, Paolo Cavanni, Romano Di Fabio, Daniele Donati, (unknown), (unknown), Alfredo Paio, (unknown), Paola Zarantonello	27
6	From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-β-carbolines: A new class of orally bioavailable mGluR1 antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Romano Di Fabio, Fabrizio Micheli, Giuseppe Alvaro, Paolo Cavanni, Daniele Donati, (unknown), Gabriele Fontana, Riccardo Giovannini, (unknown), (unknown), (unknown), Giovanni Vitulli	26
7	Structure-Activity Studies on Neuropeptide S 2006 ·Journal of Biological Chemistry ·Adelheid Roth, Erika Marzola, Anna Rizzi, (unknown), Claudio Trapella, Corrado Corti, Raffaella Vergura, (unknown), Severo Salvadori, D. Regoli, Mauro Corsi, Paolo Cavanni, Girolamo Calò, Remo Guerrini	85
8	From pyrroles to pyrrolo[1,2-a]pyrazinones: A new class of mGluR1 antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli, Paolo Cavanni, Romano Di Fabio, Carla Marchioro, Daniele Donati, (unknown), (unknown), Fabio Maria Sabbatini, (unknown)	10
9	In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen⁵,DTrp⁷,Dab⁸]urotensin II(4–11) (UFP‐803) 2005 ·British Journal of Pharmacology ·Valeria Camarda, (unknown), Wei Song, Raffaella Vergura, Adelheid Roth, Jonathan P. Thompson, David J. Rowbotham, Remo Guerrini, Erika Marzola, Severo Salvadori, Paolo Cavanni, D. Regoli, Stephen A. Douglas, David G. Lambert, Girolamo Calò	28
10	Stereoselective synthesis and preliminary evaluation of (+)- and (–)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): identification of (+)-3-MATIDA as a novel mGluR1 competitive antagonist 2004 ·Il Farmaco ·Gabriele Costantino, Maura Marinozzi, Emidio Camaioni, Benedetto Natalini, (unknown), Fabrizio Micheli, Paolo Cavanni, (unknown), Christian R. Noe, Flavio Moroni, Roberto Pellicciari	9
11	3-Methyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester: an exploration of the C-2 position. Part I 2004 ·Il Farmaco ·Fabrizio Micheli, Romano Di Fabio, (unknown), Anna Maria Capelli, (unknown), Paolo Cavanni, (unknown), Daniele Donati, Aldo Feriani, (unknown), Mahmoud Hamdan, (unknown), Fabio Maria Sabbatini, (unknown), (unknown)	17
12	3-Methyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester: an exploration of the C-2 position. Part II, A solid-phase approach 2004 ·Il Farmaco ·Fabrizio Micheli, Romano Di Fabio, (unknown), Paolo Cavanni, Daniele Donati, Mahmoud Hamdan, Fabio Maria Sabbatini, (unknown)	2
13	2,4-Dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists: an exploration of the role of the pyrrolic scaffold 2003 ·Il Farmaco ·Fabrizio Micheli, Romano Di Fabio, Paolo Cavanni, Daniele Donati, (unknown), (unknown), (unknown), Carla Marchioro, Fabio Maria Sabbatini, Giorgio Tarzia, (unknown), (unknown)	5
14	2,4-Dicarboxy-pyrroles as selective non-Competitive mGluR1 antagonists: further characterization of 3,5-Dimethyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-Trimethyl-propyl) ester and structure–Activity relationships 2003 ·Bioorganic & Medicinal Chemistry Letters ·Fabrizio Micheli, Romano Di Fabio, Fabio Bordi, (unknown), Paolo Cavanni, Daniele Donati, (unknown), (unknown), Fabio Maria Sabbatini, Giorgio Tarzia, (unknown)	20
15	Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo 2003 ·Synapse ·Christian Heidbreder, Massimiliano Bianchi, Laurent Lacroix, (unknown), (unknown), Rosaria Remelli, Paolo Cavanni, Francesco Crespi	65
16	Different Levels of Receptor Expression as a New Procedure to Estimate Agonist Affinity Constant 1997 ·Annals of the New York Academy of Sciences ·Corrado Corti, Paolo Cavanni, (unknown), Francesco Ferraguti, M. Corsi, David G. Trist	2
17	Pharmacological analysis of carboxyphenylglycines at metabotropic glutamate receptors 1994 ·European Journal of Pharmacology Molecular Pharmacology ·Paolo Cavanni, (unknown), Manolo Mugnaini, David G. Trist, F. Th. M. van Amsterdam, Francesco Ferraguti	20
18	Competitive Antagonism by Phenylglycine Derivatives at Type 1 Metabotropic Glutamate Receptors 1994 ·Molecular and Cellular Neuroscience ·Francesco Ferraguti, Paolo Cavanni, Harald Eistetter, (unknown), Emiliangelo Ratti, David G. Trist	12
19	Smooth muscle myosin light chain kinase: Rapid purification by anion exchange high-performance liquid chromatography 1990 ·Biochemical and Biophysical Research Communications ·Luciano Dalla Libera, (unknown), (unknown), Paolo Cavanni, Emiliangelo Ratti, G. Gaviraghi	3
20	Caldesmon: Anomalous electrophoretic behaviour in polyacrylamide gel 1989 ·Biochemical and Biophysical Research Communications ·Paolo Cavanni, (unknown), Emiliangelo Ratti, G. Gaviraghi, Luciano Dalla Libera	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact